QIAGEN Announces Change in Global Sales Structure
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
QIAGEN N.V. has announced that it has decided to integrate its global sales resources into its Business Areas (Life Sciences, Molecular Diagnostics and Bioinformatics). This transition is expected to allow the Business Areas to oversee the full value chain from innovation to commercialization, which is expected to further increase focus and agility. QIAGEN plans to provide an update during the fourth quarter of 2019.
QIAGEN also announced that Manuel O. Mendez, Senior Vice President, Global Commercial Operations and a member of the Executive Committee, has resigned to accept a new career opportunity, and leave the Company in October 2019.
